Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program
Top Cited Papers
- 26 December 2012
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 61 (2), 196-206
- https://doi.org/10.1016/j.jacc.2012.11.005
Abstract
No abstract availableFunding Information
- Novartis
- Amgen
- Corthera
- Merck
- Roche Diagnostics
- Duke Clinical Research Unit
- Amgen
- Otsuka
- Roche Diagnostics
- NHLBI
- Amgen
- Nanosphere
- European Union
- Amgen
- Bayer
- Corthera
- Cardio3 Bioscience
- Cytokinetics
- Merck
- Novartis
- Takeda
- Teva
- Trevena
- Corthera
- Alere
- Bayer
- Cardio3Biosciences
- Celladon
- Ceva
- European Commission
- Dutch Heart Foundation
- Novartis
- Servier
- Torrent
- Vifor
This publication has 38 references indexed in Scilit:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart FailureCirculation: Heart Failure, 2011
- Hypoalbuminaemia and incident heart failure in older adultsEuropean Journal of Heart Failure, 2011
- Diuretic Strategies in Patients with Acute Decompensated Heart FailureThe New England Journal of Medicine, 2011
- Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological dataEuropean Heart Journal, 2011
- Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre‐RELAX‐AHF studyEuropean Journal of Heart Failure, 2010
- Relaxin: Review of Biology and Potential Role in Treating Heart FailureCurrent Heart Failure Reports, 2010
- Cardiovascular effects of relaxin: from basic science to clinical therapyNature Reviews Cardiology, 2009
- Physician-Determined Worsening Heart Failure: A Novel Definition for Early Worsening Heart Failure in Patients Hospitalized for Acute Heart Failure – Association with Signs and Symptoms, Hospitalization Duration, and 60-Day OutcomesCardiology, 2009
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentThe New England Journal of Medicine, 1988